Details for New Drug Application (NDA): 016403
✉ Email this page to a colleague
NDA 016403 describes HYPAQUE-CYSTO, which is a drug marketed by Ge Healthcare and is included in one NDA. Additional details are available on the HYPAQUE-CYSTO profile page.
The generic ingredient in HYPAQUE-CYSTO is diatrizoate meglumine. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
The generic ingredient in HYPAQUE-CYSTO is diatrizoate meglumine. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
Summary for 016403
| Tradename: | HYPAQUE-CYSTO |
| Applicant: | Ge Healthcare |
| Ingredient: | diatrizoate meglumine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016403
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 60% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 30% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;URETHRAL | Strength | 30% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
